ZA864915B - Medicaments and their use - Google Patents

Medicaments and their use

Info

Publication number
ZA864915B
ZA864915B ZA864915A ZA864915A ZA864915B ZA 864915 B ZA864915 B ZA 864915B ZA 864915 A ZA864915 A ZA 864915A ZA 864915 A ZA864915 A ZA 864915A ZA 864915 B ZA864915 B ZA 864915B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA864915A
Inventor
Gerhard Lohaus
Heinz Loewe
Dieter Duewel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA864915B publication Critical patent/ZA864915B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA864915A 1985-07-03 1986-07-02 Medicaments and their use ZA864915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853523705 DE3523705A1 (en) 1985-07-03 1985-07-03 MEDICINAL PRODUCTS AND THE USE THEREOF

Publications (1)

Publication Number Publication Date
ZA864915B true ZA864915B (en) 1987-02-25

Family

ID=6274794

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864915A ZA864915B (en) 1985-07-03 1986-07-02 Medicaments and their use

Country Status (11)

Country Link
EP (1) EP0216028A2 (en)
JP (1) JPS6210057A (en)
AU (1) AU5948286A (en)
DD (1) DD248056A5 (en)
DE (1) DE3523705A1 (en)
DK (1) DK314686A (en)
GR (1) GR861712B (en)
HU (1) HUT44483A (en)
PT (1) PT82901B (en)
ZA (1) ZA864915B (en)
ZM (1) ZM4886A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0420804A3 (en) * 1989-09-26 1991-11-27 Ciba-Geigy Ag Anthelmintic compounds
EP0420805A3 (en) * 1989-09-26 1991-10-16 Ciba-Geigy Ag Anthelmintic compounds
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
GB9511694D0 (en) * 1995-06-09 1995-08-02 Fujisawa Pharmaceutical Co Benzamide derivatives
DE19830431A1 (en) 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators
CA2421254C (en) * 2000-08-30 2008-11-25 Primecyte, Inc. Methods for treating tumors using sulfonyl compounds
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
KR20070054691A (en) * 2004-09-23 2007-05-29 쉐링-프라우 리미티드 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
JPWO2006077901A1 (en) * 2005-01-20 2008-06-19 塩野義製薬株式会社 CTGF expression inhibitor
JP5149003B2 (en) 2005-06-21 2013-02-20 三井化学アグロ株式会社 Amide derivatives and insecticides containing the compounds
EP2990403A1 (en) * 2014-08-29 2016-03-02 Novartis Tiergesundheit AG Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
JP7357009B2 (en) 2018-06-01 2023-10-05 プロメガ コーポレイション Inhibitor of OPLOPHORUS luciferase-derived bioluminescent complex

Also Published As

Publication number Publication date
JPS6210057A (en) 1987-01-19
HUT44483A (en) 1988-03-28
GR861712B (en) 1986-10-31
DK314686D0 (en) 1986-07-02
DE3523705A1 (en) 1987-01-08
DK314686A (en) 1987-01-04
AU5948286A (en) 1987-01-08
DD248056A5 (en) 1987-07-29
PT82901A (en) 1986-08-01
ZM4886A1 (en) 1987-03-27
EP0216028A2 (en) 1987-04-01
PT82901B (en) 1989-01-30

Similar Documents

Publication Publication Date Title
DE3666855D1 (en) Alcalisilicate compositions and their use
PH21850A (en) Dialkoxypyridines,their use and medicaments containing them
GB2183886B (en) Microbook and its associated bookgenerator unit
EP0219458A3 (en) Medicament adsorbates and their preparation
ZA863957B (en) Alfuzosine compositions and use
EP0204659A3 (en) Polyepoxydes and their use
GB2184653B (en) Dementia-improving and therapeutic agents
NZ217637A (en) Arylmethylimidazoles and antimycotic and antidepressant medicaments
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
GR861712B (en) Medicaments and their use
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
ZA862351B (en) Drug,preparation and use thereof
GB2183638B (en) Polyfluoroalkylisoxazolylamines, their preparation and use
DE3661015D1 (en) Copolymerizable dibenzalacetone-palladium complexes and their use
ZA869694B (en) Azoniaspironortropanol esters and their pharmaceutical use
EP0255801A3 (en) Anilinotriazines and their use
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
GB8629568D0 (en) Therapeutic agent
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
DE3666044D1 (en) Bisindoline pigments and their use
GR861115B (en) New medicine
NZ215936A (en) Rioprostil - pvp complex and pharmaceutical compositions
DE3662058D1 (en) Leather-treating agent and its use
GR860180B (en) Compositions and their use